![]() |
Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon B
ADCs are used for a new type of targeted therapy that consists of a specific anti-cancer antibody or antibody fragment linked to a potent anti-cancer therapeutic.
More... |
| All times are GMT -7. The time now is 09:31 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021